Northpond Ventures, LLC - Q3 2022 holdings

$143 Million is the total value of Northpond Ventures, LLC's 5 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 0.0% .

 Value Shares↓ Weighting
 DICE THERAPEUTICS INC$66,779,000
+30.7%
3,292,8710.0%46.80%
-3.9%
 VIGIL NEUROSCIENCE INC$38,352,000
+252.7%
4,214,4980.0%26.88%
+159.5%
DNAY  CODEX DNA INC$16,341,000
-7.8%
9,844,1300.0%11.45%
-32.1%
 ISOPLEXIS CORP$15,151,000
-20.4%
8,808,5310.0%10.62%
-41.4%
 CANDEL THERAPEUTICS INC$6,077,000
-3.1%
1,935,2150.0%4.26%
-28.7%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
TELESIS BIO INC8Q3 202337.2%
CANDEL THERAPEUTICS INC8Q3 20236.0%
VIGIL NEUROSCIENCE INC7Q3 202365.8%
DICE THERAPEUTICS INC6Q1 202355.7%
ISOPLEXIS CORP5Q4 202228.3%
PHENOMEX INC2Q2 20234.4%

View Northpond Ventures, LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
SC 13D/A2023-06-02
13F-HR2023-05-15
13F-HR2023-02-01
13F-HR2022-11-14
13F-HR2022-08-01
13F-HR2022-05-16
13F-HR2022-02-15

View Northpond Ventures, LLC's complete filings history.

Export Northpond Ventures, LLC's holdings